Announcement

Collapse
No announcement yet.

Research Articles Abstract - 2010 Issues Archive

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Re: Research Articles Abstracts - April 17, 2010

    what's the best way to keep updated here ?

    currently I'm doing :

    then "influenza"
    then "hide extracts" or "show extracts" depending on how much time I want to spend..

    I noticed that sometimes hubmed is not as actual a pubmed


    or:
    PubMed® comprises more than 36 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.

    influenza
    Results: 1 to 20 of 55049
    Display Settings
    *summary/text *100 *recently added


    best would be (IMO) just the headlines , no authors, no journal name,
    one line per clickable headline
    and then store the whole list for keyword-search

    the same could be done with all the abstracts included

    is it being done ? is it allowed (copyright) ?
    I'm interested in expert panflu damage estimates
    my current links: http://bit.ly/hFI7H ILI-charts: http://bit.ly/CcRgT

    Comment


    • #17
      Re: Research Articles Abstracts - April 17, 2010

      HubMed seems a nice tools.

      My lists are based upon a weekly newsletter dispatched by a review.

      However, since this service is sponsored by a drug company I cannot disclose the name in adherence of FluTrackers.com policy.

      Other contributors can add their suggests for a better coverage of these topics.

      Comment


      • #18
        Re: Research Articles Abstracts - April 17, 2010

        last 200, no links yet

        Code:
        Isolation and molecular characterization of a H5N1 virus isolated from a Junglecrow (Corvus macrohynchos) in India. [164]
        Experimental modeling of viral diseases of the locomotor system. [165]
        [A histopathological study on Influenza A H1N1 infection in humans.] [166]
        Update: influenza activity - United States, August 30, 2009-March 27, 2010, andcomposition of the 2010-11 influenza vaccine. [167]
        Zinc Intake and Resistance to H1N1 Influenza. [168]
        [Characteristics of hepatitis and influenza antivirals: update 2009.] [169]
        Risk factors for detection of bronchial casts, most frequently seen in endemicH9N2 avian influenza infection, in poultry flocks in Iran. [170]
        A randomized controlled trial of low-dose recombinant human interferonsalpha-2b nasal spray to prevent acute viral respiratory infections in militaryrecruits. [171]
        Long-term immunogenicity of influenza vaccine among the elderly: Risk factorsfor poor immune response and persistence. [172]
        The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virusamongst hospitalised immunocompromised patients in Scotland, November-December,2009. [173]
        Association of D222G substitution in haemagglutinin of 2009 pandemic influenzaA (H1N1) with severe disease. [174]
        Changes in receiving preventive care services among US adults with diabetes,1997-2007. [175]
        Identification of Hits as Matrix-2 Protein Inhibitors through the FocusedScreening of a Small Primary Amine Library. [176]
        Cardiac tamponade and heart failure due to myopericarditis as a presentation ofinfection with the pandemic H1N1 2009 influenza A virus. [177]
        Epidemiologic Study of Human Influenza Infection in Korea from 1999 to 2007:Origin and Evolution of A/Fujian/411/2002-like strains. [179]
        Characterization of H5N2 influenza viruses isolated in South Korea and theirinfluence on the emergence of a novel H9N2 influenza virus. [181]
        Evolution of highly pathogenic avian H5N1 influenza viruses and the emergenceof dominant variants. [183]
        In vitro assessment of attachment pattern and replication efficiency of H5N1influenza A viruses with altered receptor specificity. [185]
        Myocarditis associated with 2009 influenza A (H1N1) virus in children. [187]
        Clinical features of H1N1 2009 infection in critically ill immunocompromisedpatients. [189]
        The essentiality of alpha-2-macroglobulin in human salivary innate immunityagainst new H1N1 swine origin influenza A virus. [191]
        An outbreak of H7N6 low pathogenic avian influenza in quails in Japan. [193]
        Isolation of influenza A viruses from pigs in Ibadan, Nigeria. [195]
        Standardisation of a new model of H9N2/Escherichia coli challenge in broilersin the Lebanon. [197]
        Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virusrepresent a risk factor, an acute trigger, or both? [198]
        Susceptibility of two species of wild terrestrial birds to infection with ahighly pathogenic avian influenza virus of H5N1 subtype. [200]
        Evaluation of different serological tests for the detection of antibodiesagainst highly pathogenic avian influenza in experimentally infected ostriches(Struthio camelus). [202]
        Sequence and phylogenetic analysis of the haemagglutinin genes of H9N2 avianinfluenza viruses isolated from commercial chickens in Iran. [204]
        CD28 and IL-4: two heavyweights controlling the balance between immunity andinflammation. [206]
        Pandemic influenza: antiviral preparedness and health care workers. [208]
        Which health care workers were most affected during the spring 2009 H1N1pandemic? [210]
        Heterosubtypic neutralizing antibodies are produced by individuals immunizedwith a seasonal influenza vaccine. [212]
        2009 influenza A(H1N1) seroconversion rates and risk factors among distinctadult cohorts in Singapore. [214]
        A Computational Analysis of the Antigenic Properties of Haemagglutinin inInfluenza A H3N2. [216]
        Reporting bias in medical research - a narrative review. [218]
        [Characterization of human coronavirus 229E infection among patients withrespiratory symptom in Beijing, Oct-Dec, 2007] [220]
        Faceoff: Cuba vs. H1N1 influenza. [222]
        Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Dryingand Storage. [224]
        Genetic variation of Italian avian paramyxoviruses serotype 9. [226]
        Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-inducedpro-inflammatory cytokine and chemokine expression in human macrophages. [228]
        Dynamics and control of diseases in networks with community structure. [230]
        Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1illness during Spring-Summer 2009: four observational studies from Canada.[233]
        Does seasonal influenza vaccination increase the risk of illness with the 2009A/H1N1 pandemic virus? [236]
        Economic appraisal of Ontario's Universal Influenza Immunization Program: acost-utility analysis. [239]
        Spatial and temporal association of outbreaks of H5N1 influenza virus infectionin wild birds with the 0 degrees C isotherm. [242]
        Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled,randomized, double-blind crossover study. [245]
        Utility of Influenza Vaccination for Oncology Patients. [247]
        Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1Protein. [249]
        Detection of the rapid emergence of the H275Y mutation associated withoseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.[251]
        Computational study of drug binding to the membrane-bound tetrameric M2 peptidebundle from influenza A virus. [253]
        Perception of epidemic's related anxiety in the General French Population: across-sectional study in the Rhone-Alpes region. [255]
        Metabolic engineering for the production of shikimic acid in an evolvedEscherichia coli strain lacking the phosphoenolpyruvate: carbohydratephosphotransferase system. [257]
        FLU, an amino acid substitution model for influenza proteins. [259]
        Diagnostic accuracy of bedside antigen tests to correctly diagnose newInfluenza A/H1N1v Infection. [261]
        [Influence of novel influenza pandemic in 2009 on mental state of workers atlocal public hospital: an investigation using questionnaire] [263]
        Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specificsialyltransferase. [265]
        Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenzavirus affect pathogenicity in mallard ducks. [267]
        Searching PubMed during a pandemic. [269]
        Lymphocyte to monocyte ratio as a screening tool for influenza. [272]
        A cross-sectional survey of influenza A infection and management practices insmall rural backyard poultry flocks in New Zealand. [275]
        A cross-sectional survey of biosecurity practices on Thoroughbred stud farms inNew Zealand. [277]
        Quantifying the contribution of leading causes of death to mortality declineamong older people in England, 1991-2005. [279]
        Influenza virus activates inflammasomes via its intracellular M2 ion channel.[281]
        Structures of influenza A proteins and insights into antiviral drug targets.[283]
        [Mathematical Modeling of the Novel Influenza A (H1N1) Virus and Evaluation ofthe Epidemic Response Strategies in the Republic of Korea.] [285]
        [The evaluation of policies on 2009 influenza pandemic in Korea.] [287]
        [National Level Response to Pandemic (H1N1) 2009.] [289]
        Pathology and Viral Antigen Distribution of Lethal Pneumonia in Domestic CatsDue to Pandemic (H1N1) 2009 Influenza A Virus. [291]
        Variability in Pathobiology of South Korean H5N1 High-Pathogenicity AvianInfluenza Virus Infection for 5 Species of Migratory Waterfowl. [293]
        Early host responses to avian influenza A virus are prolonged and enhanced attranscriptional level depending on maturation of the immune system. [295]
        Generation and characterization of a fusion protein of single-chain fragmentvariable antibody against hemagglutinin antigen of avian influenza virus andtruncated protamine. [297]
        Echinacea purpurea aerial extract alters course of influenza infection in mice.[299]
        Optimal control for pandemic influenza: The role of limited antiviral treatmentand isolation. [301]
        Detection of pandemic (H1N1) 2009 influenza virus by allele discrimination.[303]
        Fab MAbs Specific to HA of Influenza Virus with H5N1 Neutralizing ActivitySelected from Immunized Chicken Phage Library. [305]
        Where does amantadine bind to the influenza virus M2 proton channel? [307]
        [A(H1N1) influenza surveillance in the french armed forces: Adapting thesurveillance systems to the pandemic setting.] [309]
        Challenge and polymorphism analysis of the novel A (H1N1) influenza virus tonormal animals. [311]
        Visual Detection of Pandemic Influenza A H1N1 Virus 2009 by ReverseTranscription Loop-Mediated Isothermal Amplification with Hydroxynaphthol BlueDye. [313]
        Click reaction synthesis of carbohydrate derivatives from ristocetin aglyconwith antibacterial and antiviral activity. [315]
        Central European Vaccination Advisory Group (CEVAG) guidance statement onrecommendations for 2009 pandemic influenza A(H1N1) vaccination. [317]
        Comparison of Adjuvant Efficacy of Chitosan and Aluminum Hydroxide forIntraperitoneally Administered Inactivated Influenza H5N1 Vaccine. [319]
        Mixed Infections of Pandemic H1N1 and Seasonal H3N2 Viruses in 1 Outbreak.[321]
        Modelling the Transmission Dynamics and Control of the Novel 2009 SwineInfluenza (H1N1) Pandemic. [323]
        Influenza A (H1N1) pneumonia in an immunossupressed patient after hearttransplantation. [325]
        [Evaluation of a rapid antigenic method in the diagnosis of pandemic influenzaA (H1N1) virus in the pediatric population.] [327]
        Improving emergency preparedness capability of rural public health personnel inChina. [329]
        Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1,NIBRG-14) vaccine administered by intramuscular or subcutaneous injection.[331]
        Viral Shedding and Clinical Illness in Naturally Acquired Influenza VirusInfections. [333]
        Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy OlderAdults. [335]
        Invasive Group A Streptococcal Infection Concurrent with 2009 H1N1 Influenza.[337]
        Influenza vaccine coverage in age-related risk groups in Poland, 2004-2007.[339]
        Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenzaand seasonal influenza during the "PROTECT" phase of the pandemic response.[341]
        [Assessment of current disinfectants to create a reserve in case of avianinfluenza outbreak] [343]
        Monitoring of all-cause mortality in Belgium (Be-MOMO): a new and automatedsystem for the early detection and quantification of the mortality impact ofpublic health events. [345]
        Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)vvirus from recent human influenza viruses by real-time PCR. [347]
        Features of the new pandemic influenza A/H1N1/2009 virus: virology,epidemiology, clinical and public health aspects. [350]
        Occupational respiratory infections. [352]
        Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-AdjuvantedPrepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years: A PhaseII, Randomized, Open, Controlled Study. [354]
        Enhancement of Antiviral Activity of Collectin Trimers through Cross-Linkingand Mutagenesis of the Carbohydrate Recognition Domain. [356]
        Verification of Poultry Carcass Composting Research through Application duringActual Avian Influenza Outbreaks. [358]
        Frequent Detection of Pandemic (H1N1) 2009 Virus in Stools of HospitalizedPatients. [360]
        Targeting pandemic influenza: a primer on influenza antivirals and drugresistance. [362]
        Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans inviral evolution and vaccine design. [364]
        H1N1: can a pandemic cycle be broken? [366]
        Targeting Robo4-dependent slit signaling to survive the cytokine storm insepsis and influenza. [368]
        Pig in a china shop: a personal perspective of how pandemic (H1N1) 2009affected the work of intensive care units in NSW. [370]
        Lessons from the NSW laboratory response to pandemic (H1N1) 2009 influenza.[372]
        Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW. [374]
        Responding to pandemic (H1N1) 2009 influenza in Aboriginal communities in NSWthrough collaboration between NSW Health and the Aboriginalcommunity-controlled health sector. [376]
        Reflections on public health surveillance of pandemic (H1N1) 2009 influenza inNSW. [378]
        An influenza prophylaxis clinic in a primary school: 24 hours from notificationto protection. [380]
        Isolation and quarantine during pandemic (H1N1) 2009 influenza in NSW: theoperational experience of public health units. [382]
        Pandemic (H1N1) 2009 influenza in NSW: an overview of the public healthresponse. [384]
        Immunogenicity of avian H5N1 influenza virus recombinant vaccines in cats.[386]
        Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.[388]
        Analyses of the specificity of CD4 T cells during the primary immune responseto influenza virus reveals dramatic MHC-linked asymmetries in reactivity toindividual viral proteins. [390]
        New tests for an old foe: an update on influenza screening. [392]
        Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis)infected with highly pathogenic avian influenza A (H5N1) virus. [394]
        Viral fusion: how Flu induces dimples on liposomes. [396]
        Perception and acceptance of intradermal influenza vaccination: Patientreported outcomes from phase 3 clinical trials. [398]
        Immunogenicity, large scale safety and lot consistency of an intradermalinfluenza vaccine in adults aged 18-60 years: Randomized, controlled, phase IIItrial. [400]
        Influenza A infection triggers thrombotic thrombocytopenic purpura by producingthe anti-ADAMTS13 IgG inhibitor. [402]
        High Titers of Hemagglutination Inhibition Antibodies against 2009 H1N1Influenza Virus in Southern Iran. [404]
        Financial effects of the highly pathogenic avian influenza outbreaks on theTurkish broiler producers. [406]
        Quality of care among obese patients. [408]
        Should we "rescue" patients with 2009 influenza A(H1N1) and lung injury fromconventional mechanical ventilation? [410]
        Vaccines with MF59 adjuvant expand the antibody repertoire to target protectivesites of pandemic avian H5N1 influenza virus. [412]
        Seasonal influenza vaccine provides priming for A/H1N1 immunization. [414]
        Response network analysis of differential gene expression in human epitheliallung cells during avian influenza infections. [416]
        Molecular epidemiology and antigenic analyses of influenza A Viruses H3N2 inTaiwan. [418]
        Modeling the viral dynamics of influenza a virus infection. [420]
        Satisfying the need for rapid diagnosis of new variant influenza A H1N1. [422]
        Safety and immunogenicity of influenza A H1N1 vaccines. [424]
        2009 Pandemic H1N1 Influenza Virus Replicates in Human Lung Tissues. [426]
        Antibody Responses of Raccoons Naturally Exposed to Influenza A Virus. [428]
        Occurrence of Influenza A(H1N1)v Virus in Western Romania in Relationship toInternational Travel. [430]
        Multiple Introduction of Asian H5N1 Avian Influenza Virus in Croatia by WildBirds During 2005-2006 and Isolation of the Virus from Apparently HealthyBlack-Headed Gulls (Larus ridibundus). [432]
        Tongue swelling complicating management of a ventilated patient with acuterespiratory distress syndrome secondary to novel influenza A (H1N1). [434]
        [Contemporary threat of influenza virus infection] [436]
        Immunogenicity of three different influenza vaccines against homologous andheterologous strains in nursing home elderly residents. [438]
        Functional glycosylation of dystroglycan is crucial for thymocyte developmentin the mouse. [441]
        Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versusOseltamivir as Treatment for Children with Influenza Virus Infection. [444]
        Safety of Influenza Vaccine Administration in Egg-Allergic Patients. [446]
        [The diagnostic value of fluorescence quantitative PCR in screening ofinfluenza A virus.] [448]
        [Report of 2 cases of novel influenza A (H1N1) virus infection complicated withpneumonia and hypoxemia.] [450]
        [Clinical features of 127 cases of novel influenza A (H1N1) infection in FujianProvince.] [452]
        [Clinical experience of successful management of the first human case withsevere influenza A H1N1 virus infection in Guiyang city.] [454]
        [Clinical characteristics and analysis of imaging in patients with severeinfluenza A H1N1 virus infection.] [456]
        [Clinical experience in the treatment of a pregnant woman suffering frominfluenza A H1N1 virus infection associated with acute respiratory distresssyndrome.] [458]
        [Clinical analysis of 75 patients with severe influenza A H1N1 in QinghaiProvince.] [460]
        [The use of extracorporeal membrane oxygenation in sustaining pulmonaryfunction patients with influenza A H1N1.] [462]
        [Eighteen cases of 2009 influenza A H1N1 associated with respiratory failure inadults.] [464]
        [Treatment of critically ill influenza A H1N1 patients in plateau region.][466]
        [The lung protection strategy under the support of extracorporeal membraneoxygenation in patients suffering from influenza A H1N1.] [468]
        A universal long-term flu vaccine may not prevent severe epidemics. [470]
        Personal Choice or Evidence-Based Nursing Intervention: Nurses' Decision-Makingabout Influenza Vaccination. [472]
        A collaborative approach to meeting the psychosocial needs of children duringan influenza pandemic. [474]
        Examining the knowledge of and attitudes to pandemic influenza among generalpractice staff. [476]
        Use of phylogenetics in the molecular epidemiology and evolutionary studies ofviral infections. [478]
        Pandemic influenza: severity must be taken into account. [480]
        Quasispecies of the D225G Substitution in the Hemagglutinin of PandemicInfluenza A(H1N1) 2009 Virus from Patients with Severe Disease in Hong Kong,China. [482]
        Unexplained increased incidence of Legionnaires disease during the "HeraldWave" of the H1N1 influenza pandemic. [484]
        Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009influenza virus. [486]
        [Identification of a pandemic influenza virus A/H1N1 by real-time PCR] [488]
        [Influenza and acute respiratory viral infections. A role of a polyclinictherapist in timely diagnosis and treatment] [490]
        [Antiviral activity of sulfated polysaccharide from the brown algae Laminariajaponica against avian influenza A (H5N1) virus infection in the culturedcells] [492]
        Establish the habit: influenza vaccination for health care personnel. [494]
        Consultation with health care professionals and influenza immunization amongwomen in contact with young children. [496]
        Another Nightmare After Sars: Knowledge Perceptions of and OvercomingStrategies for H1N1 Influenza Among Chronic Renal Disease Patients in HongKong. [498]
        RESPIRATORY VIRUSES IN ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA. [500]
        Limited compatibility of polymerase subunit interactions in influenza A and Bviruses. [502]
        Pandemic H1N1 Influenza in the Pediatric Emergency Department: A ComparisonWith Previous Seasonal Influenza Outbreaks. [504]
        Impact of oseltamivir treatment on the incidence and course of acute otitismedia in children with influenza. [506]
        Characteristics of US public schools with reported cases of novel influenza A(H1N1). [508]
        Characterization of two low pathogenic avian influenza viruses isolated inHungary in 2007. [510]
        Increasing influenza vaccination rates: Where is the behaviour change theory?[512]
        Validation of a method for preparing influenza H5N1 simulated samples. [514]
        Influenza virus infection in multinucleated skeletal myofibers. [516]
        Characterization of the interaction of influenza virus NS1 with Akt. [518]
        Etiology of bronchiolitis in a hospitalized pediatric population: Prospectivemulticenter study. [520]
        [Frequency of adverse reactions after influenza vaccination in health carepersonnel of a university hospital in Spain.] [522]
        Development of a multiplex real-time RT-PCR assay for detection of influenza A,influenza B, RSV and typing of the 2009-H1N1 influenza virus. [524]
        A protein chip designed to differentiate visually antibodies in chickens whichwere infected by four different viruses. [526]
        The non-structural (NS1) protein of influenza A virus associates with p53 andinhibits p53-mediated transcriptional activity and apoptosis. [528]
        [Review on the etiological property of the swine influenza virus] [530]
        [Laboratory confirmation of the first influenza A (H1N1) imported case inMainland China] [532]
        [Establishment of a method for rapid detection of the nucleic acid of the novelA (H1N1) influenza virus] [534]
        Evaluation of the efficacy of a specific hyperimmune serum in experimentalinfluenza infection in mice. [536]
        Deaths: leading causes for 2005. [537]
        An anti-influenza component of the bark of Alnus japonica. [539]
        Total synthesis of (+)-stachyflin: a potential anti-influenza A virus agent.[541]
        Estimating the disease burden of pandemic (H1N1) 2009 virus infection in HunterNew England, Northern New South Wales, Australia, 2009. [543]
        Contribution of company affiliation and social contacts to risk estimates ofbetween-farm transmission of avian influenza. [546]
        Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccinationcoverage - United States, October 2009-January 2010. [549]
        Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenzavaccination coverage among health-care personnel - United States, August2009-January 2010. [551]
        [Impact on the population of media campaigns on the influenza H1N1A pandemic.Incidence on the act of shaking hands on saying goodbye, in a rural healthcentre.] [553]
        A novel mitogen fusion protein against CD40(+) cells with potent vaccineadjuvant properties. [555]
        Accuracy of online health information about controlling childhood fever duringthe H1N1 influenza pandemic. [557]
        Non-invasive ventilation in acute respiratory failure related to 2009 pandemicInfluenza A/H1N1 virus infection. [559]
        I'm interested in expert panflu damage estimates
        my current links: http://bit.ly/hFI7H ILI-charts: http://bit.ly/CcRgT

        Comment


        • #19
          Research Articles Abstracts - April 23 2010 Issue

          [Source: US National Library of Medicine, (LINK). Edited.]

          Research Articles Abstracts - April 23 2010 Issue

          1. Mayor S.
            • Department of Health agrees deal with GSK to cancel part of swine flu vaccine order.
            • BMJ. 2010;340:c1946.
            • PubMed
          2. Watson R.
            • WHO is accused of "crying wolf" over swine flu pandemic.
            • BMJ. 2010;340:c1904.
            • PubMed
          3. Kim SH, Samal S.
            • Inhibition of Host Innate Immune Responses and Pathogenicity of Recombinant Newcastle Disease Viruses Expressing NS1 Genes of Influenza A Viruses.
            • J Gen Virol. 2010.
            • PubMed
            • Abstract available
          4. Dimenna L, Latimer B, Parzych E, Haut LH, et al.
            • Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway.
            • J Immunol. 2010.
            • PubMed
            • Abstract available
          5. Campbell AP, Chien JW, Kuypers J, Englund JA, et al.
            • Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
            • J Infect Dis. 2010;201:1404-13.
            • PubMed
            • Abstract available
          6. Lynfield R.
            • Lessons from Queens.
            • J Infect Dis. 2010;201:973-5.
            • PubMed
          7. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, et al.
            • Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected by Influenza A Virus.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          8. Soubies SM, Volmer C, Croville G, Loupias J, et al.
            • Species-specific Contribution of the Four C-terminal Amino Acids of Influenza A NS1 Protein to Virulence.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          9. Lin YP, Gregory V, Collins P, Kloess J, et al.
            • Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses due to Substitution of Aspartic acid 151 in the Catalytic Site - Role in Virus Attachment?
            • J Virol. 2010.
            • PubMed
            • Abstract available
          10. Tu W, Mao H, Zheng J, Liu Y, et al.
            • Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-react against 2009 Pandemic H1N1 Influenza Virus.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          11. Siston AM, Rasmussen SA, Honein MA, Fry AM, et al.
            • Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
            • JAMA. 2010;303:1517-25.
            • PubMed
            • Abstract available
          12. Huang WT, Chuang JH, Kuo SH.
            • Monitoring the safety of pandemic H1N1 vaccine.
            • Lancet. 2010;375:1164.
            • PubMed
          13. Destefano F, Tokars J.
            • H1N1 vaccine safety monitoring: beyond background rates.
            • Lancet. 2009.
            • PubMed
          14. # ...
            • Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.
            • MMWR Morb Mortal Wkly Rep. 2010;59:423-30.
            • PubMed
            • Abstract available
          15. Liljebjelke KA, Petkov DI, Kapczynski DR.
            • Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          16. Prieto-Lara E, Mendez AL.
            • Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          17. Chen Z, Zhou H, Jin H.
            • The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          18. Stephenson I, Hayden F, Osterhaus A, Howard W, et al.
            • Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          19. Song JY, Cheong HJ, Hwang IS, Choi WS, et al.
            • Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          20. Abed Y, Simon P, Boivin G.
            • Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation.
            • Antimicrob Agents Chemother. 2010.
            • PubMed
            • Abstract available

          -
          ------

          Comment


          • #20
            Research Articles Abstracts - April 30, 2010 Issue

            [Source: US National Library of Medicine, (LINK). Edited.]

            Research Articles Abstracts - April 30, 2010 Issue


            1. Ison MG, de Jong MD, Gilligan KJ, Higgs ES, et al.
              • End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease.
              • J Infect Dis. 2010.
              • PubMed
              • Abstract available
            2. Langley JM, Frenette L, Ferguson L, Riff D, et al.
              • Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults.
              • J Infect Dis. 2010.
              • PubMed
              • Abstract available
            3. Steinhoff MC, Omer SB, Roy E, Arifeen SE, et al.
              • Influenza immunization in pregnancy -- antibody responses in mothers and infants.
              • N Engl J Med. 2010;362:1644-6.
              • PubMed
            4. Valleron AJ, Cori A, Valtat S, Meurisse S, et al.
              • Transmissibility and geographic spread of the 1889 influenza pandemic.
              • Proc Natl Acad Sci U S A. 2010.
              • PubMed
              • Abstract available
            5. Brown KF, Kroll JS, Hudson MJ, Ramsay M, et al.
              • Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            6. Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, et al.
              • The immunogenicity of intradermal influenza vaccination in COPD patients.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            7. Flasterstein OE, Samira S, Rochlin E, Balasingam S, et al.
              • Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            8. Rossi GA, Silvestri M, Lanari M.
              • Should the American Academy of Pediatrics respiratory syncytial virus guidelines be modified?
              • Pediatrics. 2010;125:e1021.
              • PubMed

            -
            ------

            Comment


            • #21
              Research Articles Abstract - May 10 2010 Issue

              [Source: US National Library of Medicine (LINK). Edited.]

              Research Articles Abstract - May 10 2010 Issue


              1. Campbell AP, Jacob ST, Kuypers J, Wald A, et al.
                • Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
                • Ann Intern Med. 2010;152:619-20.
                • PubMed
              2. Lee N, Chan PK, Lam WY, Szeto CC, et al.
                • Co-infection with pandemic H1N1 and seasonal H3N2 influenza viruses.
                • Ann Intern Med. 2010;152:618-9.
                • PubMed
              3. Sharshov K, Romanovskaya A, Uzhachenko R, Durymanov A, et al.
                • Genetic and biological characterization of avian influenza H5N1 viruses isolated from wild birds and poultry in Western Siberia.
                • Arch Virol. 2010.
                • PubMed
                • Abstract available
              4. Randall TD.
                • Pulmonary dendritic cells: thinking globally, acting locally.
                • J Exp Med. 2010;207:451-4.
                • PubMed
                • Abstract available
              5. Wu W, Booth JL, Duggan ES, Patel KB, et al.
                • Human lung innate immune cytokine response to adenovirus type 7.
                • J Gen Virol. 2010;91.
                • PubMed
                • Abstract available
              6. Herd KA, Nelson M, Mahalingam S, Tindle RW, et al.
                • Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.
                • J Gen Virol. 2010;91.
                • PubMed
                • Abstract available
              7. Cornberg M, Clute SC, Watkin LB, Saccoccio FM, et al.
                • CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections.
                • J Immunol. 2010.
                • PubMed
                • Abstract available
              8. Erden I, Erden EC, Ozhan H, Basar C, et al.
                • Echocardiographic manifestations of pandemic 2009 (h1n1) influenza a virus infection.
                • J Infect. 2010.
                • PubMed
                • Abstract available
              9. Li R, Lim A, Phoon MC, Narasaraju T, et al.
                • Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              10. Murcia PR, Baillie GJ, Daly J, Elton D, et al.
                • The intra- and inter-host evolutionary dynamics of equine influenza virus.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              11. Hale BG, Steel J, Medina RA, Manicassamy B, et al.
                • Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              12. Harker JA, Lee DC, Yamaguchi Y, Wang B, et al.
                • Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
                • J Virol. 2010;84:5294-302.
                • PubMed
                • Abstract available
              13. Shabat MB, Meir R, Haddas R, Lapin E, et al.
                • Development of a Real-Time TaqMan RT-PCR Assay for the Detection of H9N2 Avian Influenza Viruses.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              14. Ducatez MF, Sonnberg S, Hall RJ, Peacey M, et al.
                • Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              15. Vester D, Lagoda A, Hoffmann D, Seitz C, et al.
                • Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              16. ...
                • Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010.
                • MMWR Morb Mortal Wkly Rep. 2010;59:485-6.
                • PubMed
                • Abstract available
              17. ...
                • Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010.
                • MMWR Morb Mortal Wkly Rep. 2010;59:477-84.
                • PubMed
                • Abstract available
              18. Brownstein JS, Freifeld CC, Chan EH, Keller M, et al.
                • Information technology and global surveillance of cases of 2009 H1N1 influenza.
                • N Engl J Med. 2010;362:1731-5.
                • PubMed
              19. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, et al.
                • Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection.
                • N Engl J Med. 2010;362:1708-19.
                • PubMed
              20. Grunwald C, Schulze K, Reichel A, Weiss VU, et al.
                • In situ assembly of macromolecular complexes triggered by light.
                • Proc Natl Acad Sci U S A. 2010;107:6146-51.
                • PubMed
                • Abstract available
              21. # Rehmani R, Memon JI.
                • Knowledge, attitudes and beliefs regarding influenza vaccination among healthcare workers in a Saudi hospital.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              22. Ansaldi F, Zancolli M, Paolo D, Montomoli E, et al.
                • Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              23. Baaten BJ, Clarke B, Strong P, Hou S, et al.
                • Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              24. de Vries RP, de Vries E, Bosch BJ, de Groot RJ, et al.
                • The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.
                • Virology. 2010.
                • PubMed
                • Abstract available

              -
              -----

              Comment


              • #22
                Research Articles Abstracts - May 16 2010 Issue

                [Source: US National Library of Medicine, (LINK). Edited.]

                Research Articles Abstracts - May 16 2010 Issue


                1. Chen Y, Luo W, Wu WL, Fang Z, et al.
                  • Humanized Antibodies with Broad-Spectrum Neutralization to Avian Influenza Virus H5N1.
                  • Antiviral Res. 2010.
                  • PubMed
                  • Abstract available
                2. Sweet M.
                  • Australia suspends seasonal flu vaccination of young children.
                  • BMJ. 2010;340:c2419.
                  • PubMed
                3. Mayor S.
                  • Hospital stays for young adults with flu shot up in England in 2009.
                  • BMJ. 2010;340:c2234.
                  • PubMed
                4. Fu YH, He JS, Wang XB, Zheng XX, et al.
                  • A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus.
                  • Biochem Biophys Res Commun. 2010;395:87-92.
                  • PubMed
                  • Abstract available
                5. Williams CJ, Buchholz U.
                  • Influence of household contacts on the effectiveness of face masks for preventing influenza in a healthcare setting: a comment on Cowling et al. (2010).
                  • Epidemiol Infect. 2010.
                  • PubMed
                6. Suzuki K, Okada H, Itoh T, Tada T, et al.
                  • Phenotypes influencing transmissibility of highly pathogenic avian influenza viruses in chickens.
                  • J Gen Virol. 2010.
                  • PubMed
                  • Abstract available
                7. Shanks GD, Mackenzie A, McLaughlin R, Waller M, et al.
                  • Mortality Risk Factors During the 1918-1919 Influenza Pandemic in the Australian Army.
                  • J Infect Dis. 2010.
                  • PubMed
                  • Abstract available
                8. Li Y, Lu X, Li J, Berube N, et al.
                  • Genetic engineered, biarsenical labelled influenza virus allows visualization of viral NS1 protein in living cells.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                9. Chan WH, Ng AK, Robb NC, Lam MK, et al.
                  • Functional analysis of influenza H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                10. Huang K, Bahl J, Fan XH, Vijaykrishna D, et al.
                  • Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                11. Qin M, Wang DY, Huang F, Nie K, et al.
                  • Detection of pandemic influenza A H1N1 virus by multiplex reverse transcription-PCR with a GeXP analyzer.
                  • J Virol Methods. 2010.
                  • PubMed
                  • Abstract available
                12. Furuse Y, Odagiri T, Okada T, Khandaker I, et al.
                  • Differentiation of human influenza A viruses including the pandemic subtype H1N1/2009 by conventional multiplex PCR.
                  • J Virol Methods. 2010.
                  • PubMed
                  • Abstract available
                13. Walley T, Davidson P.
                  • Research funding in a pandemic.
                  • Lancet. 2010;375:1063-5.
                  • PubMed
                14. Lau JT, Yeung NC, Choi KC, Cheng MY, et al.
                  • Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                15. Cohen SA, Ahmed S, Klassen AC, Agree EM, et al.
                  • Childhood Hib vaccination and pneumonia and influenza burden in US seniors.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                16. Blank DL, Bodansky DM, Forbes A, Garde E, et al.
                  • Influenza vaccination of future healthcare workers: A cross-sectional study of uptake, knowledge and attitudes.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                17. Wong LP, Sam IC.
                  • Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                18. Walter EB, Rajagopal S, Zhu Y, Neuzil KM, et al.
                  • Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally?
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                19. Hull HF.
                  • LAIV efficacy in military recruits.
                  • Vaccine. 2010;28:2066.
                  • PubMed
                20. Dinh A, Lawrence C, Salomon J, Descatha A, et al.
                  • Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital.
                  • Vaccine. 2009.
                  • PubMed
                21. Zhu H, Wang J, Wang P, Song W, et al.
                  • Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice.
                  • Virology. 2010;401:1-5.
                  • PubMed
                  • Abstract available

                -
                ------

                Comment


                • #23
                  Research Articles Abstract - May 22 2010 Issue

                  [Source: US National Library of Medicine, (LINK). Edited.]

                  Research Articles Abstract - May 22 2010 Issue


                  1. Lai KY, Ng WY, Osburga Chan PK, Wong KF, et al.
                    • High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia.
                    • Ann Intern Med. 2010;152:687-8.
                    • PubMed
                  2. Kumar P, Sood V, Vyas R, Gupta N, et al.
                    • Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs.
                    • Antiviral Res. 2010.
                    • PubMed
                    • Abstract available
                  3. Acedo L, Diez-Domingo J, Morano JA, Villanueva RJ, et al.
                    • Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications.
                    • Epidemiol Infect. 2010;138:853-60.
                    • PubMed
                    • Abstract available
                  4. Cha W, Ma Y, Saif YM, Lee CW, et al.
                    • Development of microsphere-based multiplex branched DNA assay for the detection and differentiation of avian influenza virus.
                    • J Clin Microbiol. 2010.
                    • PubMed
                    • Abstract available
                  5. Ma W, Lager KM, Lekcharoensuk P, Ulery ES, et al.
                    • Viral reassortment and transmission after coinfection of pigs with classical H1N1 and triple reassortant H3N2 swine influenza viruses.
                    • J Gen Virol. 2010.
                    • PubMed
                    • Abstract available
                  6. Busquets N, Abad FX, Alba A, Dolz R, et al.
                    • Persistence of highly pathogenic avian influenza virus (H7N1) in infected chicken: feather as a suitable sample for diagnosis.
                    • J Gen Virol. 2010.
                    • PubMed
                    • Abstract available
                  7. Quan FS, Kim YC, Vunnava A, Yoo DG, et al.
                    • Intradermal vaccination with influenza VLPs using microneedles induces protection superior to intramuscular immunization.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  8. Du N, Zhou J, Lin X, Zhang Y, et al.
                    • Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  9. Boon AC, Debeauchamp J, Krauss S, Rubrum A, et al.
                    • Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 influenza mouse model.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  10. Steelfisher GK, Blendon RJ, Bekheit MM, Lubell K, et al.
                    • The Public's Response to the 2009 H1N1 Influenza Pandemic.
                    • N Engl J Med. 2010.
                    • PubMed
                  11. Partridge J, Kieny MP.
                    • Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  12. Lee BY, Brown ST, Korch G, Cooley PC, et al.
                    • A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  13. Yang CF, Belshe RB, Kemble G, Song E, et al.
                    • Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  14. Wicker S, Rabenau HF.
                    • The reluctance of nurses to get vaccinated against influenza.
                    • Vaccine. 2010.
                    • PubMed
                  15. Virseda S, Restrepo MA, Arranz E, Magan-Tapia P, et al.
                    • Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  16. Pushko P, Kort T, Nathan M, Pearce MB, et al.
                    • Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  17. Eggert D, Thomas C, Spackman E, Pritchard N, et al.
                    • Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available

                  -
                  ------

                  Comment


                  • #24
                    Research Articles Abstracts - May 29 2010 Issue

                    [Source: US National Library of Medicine, (LINK). Edited.]

                    Research Articles Abstracts - May 29 2010 Issue


                    1. OOI PL, Lai FY, Low CL, Lin R, et al.
                      • Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009)on a commercial airplane.
                      • Arch Intern Med. 2010;170:913-5.
                      • LINK
                    2. MILLER AC, Safi F, Hussain S, Subramanian RA, et al.
                      • Novel influenza A(H1N1) virus among gravid admissions.
                      • Arch Intern Med. 2010;170:868-73.
                      • ABSTRACT available
                    3. TANG JW, Tambyah PA, Lai FY, Lee HK, et al.
                      • Differing symptom patterns in early pandemic vs seasonal influenza infections.
                      • Arch Intern Med. 2010;170:861-7.
                      • ABSTRACT available
                    4. BAKER MG, Thornley CN, Mills C, Roberts S, et al.
                      • Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study.
                      • BMJ. 2010;340:c2424.
                      • ABSTRACT available
                    5. YANG P, Dongmei, Wang C, Tang C, et al.
                      • Characterization of a highly pathogenic avian influenza H5N1 virus isolated from an ostrich.
                      • Biochem Biophys Res Commun. 2010.
                      • ABSTRACT available
                    6. ANDRESEN DN, Kesson AM.
                      • High Sensitivity of a Rapid Immunochromatographic Test for the Detection of Influenza A Virus 2009 H1N1 on Nasopharyngeal Aspirates from Young Children.
                      • J Clin Microbiol. 2010.
                      • ABSTRACT available
                    7. HOSSAIN MJ, Perez S, Guo Z, Chen LM, et al.
                      • Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.
                      • J Clin Microbiol. 2010.
                      • ABSTRACT available
                    8. LAI JC, Chan WW, Kien F, Nicholls JM, et al.
                      • Formation of virus-like particles from human cell lines exclusively expressing Influenza neuraminidase.
                      • J Gen Virol. 2010.
                      • ABSTRACT available
                    9. GUO H, Topham DJ.
                      • IL-22 production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza infection.
                      • J Virol. 2010.
                      • ABSTRACT available
                    10. CHEN GL, Lamirande EW, Yang CF, Jin H, et al.
                      • EVALUATION OF REPLICATION AND CROSS-REACTIVE ANTIBODY RESPONSE OF H2 INFLUENZA SUBTYPE VIRUSES IN MICE AND FERRETS.
                      • J Virol. 2010.
                      • ABSTRACT available
                    11. DE LUCAS S, Peredo J, Marion RM, Sanchez C, et al.
                      • Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.
                      • J Virol. 2010.
                      • ABSTRACT available
                    12. LANGLEY WA, Bradley KC, Li ZN, Smith ME, et al.
                      • Induction of neutralizing antibody responses to anthrax PA using influenza vectors: Implications for disparate immune system priming pathways.
                      • J Virol. 2010.
                      • ABSTRACT available
                    13. TATE MD, Pickett DL, van Rooijen N, Brooks AG, et al.
                      • The Critical Role of Airway Macrophages in Modulating Disease Severity During Influenza Virus Infection of Mice.
                      • J Virol. 2010.
                      • ABSTRACT available
                    14. CILLONIZ C, Pantin-Jackwood MJ, Ni C, Goodman AG, et al.
                      • Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.
                      • J Virol. 2010.
                      • ABSTRACT available
                    15. CHAKRAVARTHY KV, Bonoiu AC, Davis WG, Ranjan P, et al.
                      • Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.
                      • Proc Natl Acad Sci U S A. 2010.
                      • ABSTRACT available
                    16. CALDER LJ, Wasilewski S, Berriman JA, Rosenthal PB, et al.
                      • Structural organization of a filamentous influenza A virus.
                      • Proc Natl Acad Sci U S A. 2010.
                      • ABSTRACT available
                    17. TAMURA SI.
                      • Studies on the usefulness of intranasal inactivated influenza vaccines.
                      • Vaccine. 2010.
                      • ABSTRACT available
                    18. PALMER LA, Rousculp MD, Johnston SS, Mahadevia PJ, et al.
                      • Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study.
                      • Vaccine. 2010.
                      • ABSTRACT available
                    19. MELIDOU A, Gioula G, Exindari M, Chatzidimitriou D, et al.
                      • Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections.
                      • Virus Res. 2010.
                      • ABSTRACT available
                    20. BROWN A, McSharry JJ, Weng Q, Driebe EM, et al.
                      • An In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure.
                      • Antimicrob Agents Chemother. 2010.
                      • ABSTRACT available

                    -
                    -----

                    Comment


                    • #25
                      Research Articles Abstracts - June 4 2010 Issue

                      [Source: US National Library of Medicine, (LINK). Edited.]

                      Research Articles Abstracts - June 4 2010 Issue

                      1. Waddington CS, Walker WT, Oeser C, Reiner A, et al.
                        • Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
                        • BMJ. 2010;340:c2649.
                        • PubMed
                        • Abstract available
                      2. Higgins AD, Shaw CJ, Johnson JG, Navarro A, et al.
                        • A Monoclonal Antibody Kit for Identification of the Novel 2009 H1N1 Influenza A Virus.
                        • J Clin Microbiol. 2010.
                        • PubMed
                        • Abstract available
                      3. Robb N, Jackson D, Vreede F, Fodor E, et al.
                        • Splicing of Influenza A Virus NS1 mRNA is Independent of the Viral NS1 Protein.
                        • J Gen Virol. 2010.
                        • PubMed
                        • Abstract available
                      4. Shinya K, Makino A, Hatta M, Watanabe S, et al.
                        • A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage.
                        • J Gen Virol. 2010;91.
                        • PubMed
                        • Abstract available
                      5. Stevens J, Chen LM, Carney PJ, Garten R, et al.
                        • Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      6. Manz B, Matrosovich M, Bovin N, Schwemmle M, et al.
                        • A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      7. Munster VJ, Schrauwen EJ, de Wit E, van den Brand JM, et al.
                        • Insertion of a multi basic cleavage motif into the hemagglutinin of a low pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      8. Oh HL, Akerstrom S, Shen S, Bereczky S, et al.
                        • An antibody against a novel and conserved epitope in the HA1 subunit neutralizes numerous H5N1 influenza viruses.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      9. Seo YJ, Blake C, Alexander S, Hahm B, et al.
                        • Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cyto-pathogenicity.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      10. Gao Q, Lowen AC, Wang TT, Palese P, et al.
                        • A nine-segmented influenza A virus carrying H1 and H3 subtype hemagglutinins.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      11. Govorkova EA, Ilyushina NA, Marathe BM, McClaren JL, et al.
                        • Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      12. Bodewes R, Kreijtz JH, van Amerongen G, Geelhoed-Mieras MM, et al.
                        • A single immunization with CoVaccine HTTM-adjuvanted H5N1 influenza vaccine induces protective cellular and humoral immune responses in ferrets.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      13. Berkley JA, Munywoki P, Ngama M, Kazungu S, et al.
                        • Viral etiology of severe pneumonia among Kenyan infants and children.
                        • JAMA. 2010;303:2051-7.
                        • PubMed
                        • Abstract available
                      14. ...
                        • Preliminary Results: Surveillance for Guillain-Barre Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine --- United States, 2009--2010.
                        • MMWR Morb Mortal Wkly Rep. 2010;59:657-61.
                        • PubMed
                        • Abstract available
                      15. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, et al.
                        • A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.
                        • Proc Natl Acad Sci U S A. 2010;107:8800-5.
                        • PubMed
                        • Abstract available
                      16. Turner RB, Fuls JL, Rodgers ND.
                        • Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands.
                        • Antimicrob Agents Chemother. 2010;54:1363-4.
                        • PubMed
                        • Abstract available

                      -
                      ------

                      Comment


                      • #26
                        Research Articles Abstracts - June 11 2010 Issue

                        [Source: US National Library of Medicine, (LINK). Edited.]

                        Research Articles Abstracts - June 11 2010 Issue

                        1. Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, et al.
                          • Induction of TNF-alpha in human macrophages by avian and human influenza viruses.
                          • Arch Virol. 2010.
                          • PubMed
                          • Abstract available
                        2. Voeten JT, Kiseleva IV, Glansbeek HL, Basten SM, et al.
                          • Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
                          • Arch Virol. 2010.
                          • PubMed
                          • Abstract available
                        3. Martinez M, Perez AM, DE LA Torre A, Iglesias I, et al.
                          • Evaluating surveillance in wild birds by the application of risk assessment of avian influenza introduction into Spain.
                          • Epidemiol Infect. 2010.
                          • PubMed
                          • Abstract available
                        4. Moscona A, Porotto M, Palmer S, Tai C, et al.
                          • A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo.
                          • J Infect Dis. 2010.
                          • PubMed
                          • Abstract available
                        5. Fang Y, Rowe T, Leon AJ, Banner D, et al.
                          • Molecular Characterization of in vivo Adjuvant Activity in Influenza-Vaccinated Ferrets.
                          • J Virol. 2010.
                          • PubMed
                          • Abstract available
                        6. Kirby T.
                          • Jim Bishop: the Chief Medical Officer of Australia.
                          • Lancet. 2010;375:1517.
                          • PubMed
                        7. Hall CB.
                          • Respiratory syncytial virus in young children.
                          • Lancet. 2010;375:1500-2.
                          • PubMed
                        8. Nair H, Nokes DJ, Gessner BD, Dherani M, et al.
                          • Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.
                          • Lancet. 2010;375:1545-55.
                          • PubMed
                          • Abstract available
                        9. ...
                          • Deaths and Hospitalizations Related to 2009 Pandemic Influenza A (H1N1) --- Greece, May 2009--February 2010.
                          • MMWR Morb Mortal Wkly Rep. 2010;59:682-6.
                          • PubMed
                          • Abstract available
                        10. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, et al.
                          • Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        11. Lorieau JL, Louis JM, Bax A.
                          • The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        12. Perez JT, Varble A, Sachidanandam R, Zlatev I, et al.
                          • Influenza A virus-generated small RNAs regulate the switch from transcription to replication.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        13. Kim JK, Kayali G, Walker D, Forrest HL, et al.
                          • Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available

                        -
                        -----

                        Comment


                        • #27
                          Research Articles Abstracts - June 18 2010 Issue

                          Research Articles Abstracts - June 18 2010 Issue

                          [Source: US National Library of Medicine, (LINK). Edited.]

                          Research Articles Abstracts - June 18 2010 Issue

                          1. Zarocostas J.
                            • Swine flu pandemic review panel seeks access to confidential documents between WHO and drug companies.
                            • BMJ. 2010;340:c2792.
                            • PubMed
                          2. Iglesias I, Perez AM, Sanchez-Vizcaino JM, Munoz MJ, et al.
                            • Reproductive ratio for the local spread of highly pathogenic avian influenza in wild bird populations of Europe, 2005-2008.
                            • Epidemiol Infect. 2010.
                            • PubMed
                            • Abstract available
                          3. Ajelli M, Merler S, Pugliese A, Rizzo C, et al.
                            • Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
                            • Epidemiol Infect. 2010.
                            • PubMed
                            • Abstract available
                          4. Sakai-Tagawa Y, Ozawa M, Tamura D, Le QM, et al.
                            • Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses.
                            • J Clin Microbiol. 2010.
                            • PubMed
                            • Abstract available
                          5. Zhang ZY, Du LN, Chen X, Zhao Y, et al.
                            • Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains.
                            • J Clin Microbiol. 2010;48:1201-7.
                            • PubMed
                            • Abstract available
                          6. Chen J, Huang S, Chen Z.
                            • Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/NEP protein and over-expression of its GLFG repeat domain can inhibit virus propagation.
                            • J Gen Virol. 2010.
                            • PubMed
                            • Abstract available
                          7. Sun X, Tse LV, Ferguson AD, Whittaker GR, et al.
                            • Modifications to the hemagglutinin cleavage site control virulence of a neurotropic H1N1 influenza virus.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          8. Song L, Liu H, Gao S, Jiang W, et al.
                            • Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          9. Li Y, Shi J, Zhong G, Deng G, et al.
                            • Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry and humans in China from 2004 to 2009.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          10. Graef KM, Vreede FT, Lau YF, McCall AW, et al.
                            • The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with MAVS and inhibiting IFN-{beta} expression.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          11. Lau YF, Tang LH, McCall AW, Ooi EE, et al.
                            • An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza vaccine with antigen-sparing effect in mice.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          12. Small PA Jr, Morris JG Jr.
                            • Influenza vaccination of children and infection rates in the community.
                            • JAMA. 2010;303:2355-6.
                            • PubMed
                          13. Goldkind SF, Sahin L, Gallauresi B.
                            • Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic.
                            • N Engl J Med. 2010;362:2241-3.
                            • PubMed
                          14. Scull MA, Rice CM.
                            • A big role for small RNAs in influenza virus replication.
                            • Proc Natl Acad Sci U S A. 2010.
                            • PubMed
                          15. van der Weijden CP, Bredenoord AL, van Delden JJ.
                            • The duty to treat in the context of an influenza pandemic.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          16. Sy LS, Liu IL, Solano Z, Cheetham TC, et al.
                            • Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          17. Girard MP, Tam JS, Assossou OM, Kieny MP, et al.
                            • The 2009 A (H1N1) influenza virus pandemic: A review.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          18. Lau JT, Cai Y, Tsui HY, Choi KC, et al.
                            • Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          19. Orellano PW, Reynoso JI, Carlino O, Uez O, et al.
                            • Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          20. Pu J, Wang J, Zhang Y, Fu G, et al.
                            • Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice.
                            • Virus Res. 2010.
                            • PubMed
                            • Abstract available

                          -
                          -----

                          Comment


                          • #28
                            Research Articles Abstracts - June 25 2010 Issue

                            [Source: US National Library of Medicine, (LINK). Edited.]

                            Research Articles Abstracts - June 25 2010 Issue


                            1. Qi T, Guo W, Huang WQ, Li HM, et al.
                              • Genetic evolution of equine influenza viruses isolated in China.
                              • Arch Virol. 2010.
                              • PubMed
                              • Abstract available
                            2. Moynihan R.
                              • Australian government says healthy under 5s should not be given seasonal flu jab.
                              • BMJ. 2010;340:c2991.
                              • PubMed
                            3. O'Dowd A.
                              • Council of Europe condemns "unjustified scare" over swine flu.
                              • BMJ. 2010;340:c3033.
                              • PubMed
                            4. Godlee F.
                              • Conflicts of interest and pandemic flu.
                              • BMJ. 2010;340:c2947.
                              • PubMed
                            5. Cohen D, Carter P.
                              • Conflicts of interest. WHO and the pandemic flu "conspiracies".
                              • BMJ. 2010;340:c2912.
                              • PubMed
                            6. Doyle TJ, Hopkins RS.
                              • Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure.
                              • Epidemiol Infect. 2010.
                              • PubMed
                              • Abstract available
                            7. Grantham ML, Stewart SM, Lalime EN, Pekosz A, et al.
                              • Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for the production of infectious virus particles.
                              • J Virol. 2010.
                              • PubMed
                              • Abstract available
                            8. Fislova T, Thomas B, Graef KM, Fodor E, et al.
                              • Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT.
                              • J Virol. 2010.
                              • PubMed
                              • Abstract available
                            9. Uyeki TM.
                              • 2009 H1N1 virus transmission and outbreaks.
                              • N Engl J Med. 2010;362:2221-3.
                              • PubMed
                            10. Cowling BJ, Chan KH, Fang VJ, Lau LL, et al.
                              • Comparative epidemiology of pandemic and seasonal influenza A in households.
                              • N Engl J Med. 2010;362:2175-84.
                              • PubMed
                              • Abstract available
                            11. Lee VJ, Yap J, Cook AR, Chen MI, et al.
                              • Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
                              • N Engl J Med. 2010;362:2166-74.
                              • PubMed
                              • Abstract available
                            12. Stittelaar KJ, Lacombe V, van Lavieren R, van Amerongen G, et al.
                              • Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.
                              • Vaccine. 2010.
                              • PubMed
                              • Abstract available
                            13. Kanai Y, Boonsathorn N, Chittaganpitch M, Bai G, et al.
                              • The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009.
                              • Vaccine. 2010.
                              • PubMed
                              • Abstract available
                            14. Singh S, Toro H, Tang DC, Briles WE, et al.
                              • Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.
                              • Virology. 2010.
                              • PubMed
                              • Abstract available

                            -
                            ------

                            Comment


                            • #29
                              Research Articles Abstracts - July 2 2010 Issue

                              Research Articles Abstracts - July 2 2010 Issue

                              [Source: US National Library of Medicine, (LINK). Edited.]

                              Research Articles Abstracts - July 2 2010 Issue


                              1. Palmer SM, Limaye AP, Banks M, Gallup D, et al.
                                • Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.
                                • Ann Intern Med. 2010;152:761-9.
                                • PubMed
                                • Abstract available
                              2. Pillai SP, Pantin-Jackwood M, Suarez DL, Saif YM, et al.
                                • Pathobiological characterization of low-pathogenicity H5 avian influenza viruses of diverse origins in chickens, ducks and turkeys.
                                • Arch Virol. 2010.
                                • PubMed
                                • Abstract available
                              3. Abraham T.
                                • The price of poor pandemic communication.
                                • BMJ. 2010;340:c2952.
                                • PubMed
                              4. Bonneux L, Van Damme W.
                                • Preventing iatrogenic pandemics of panic. Do it in a NICE way.
                                • BMJ. 2010;340:c3065.
                                • PubMed
                              5. Collignon P, Doshi P, Jefferson T.
                                • Child influenza vaccination. Ramifications of adverse events in children in Australia.
                                • BMJ. 2010;340:c2994.
                                • PubMed
                              6. Le QM, Ito M, Muramoto Y, Hoang PV, et al.
                                • Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans from 2003 to 2008 in Northern Vietnam.
                                • J Gen Virol. 2010.
                                • PubMed
                                • Abstract available
                              7. Skountzou I, Koutsonanos DG, Kim JH, Powers R, et al.
                                • Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus.
                                • J Immunol. 2010.
                                • PubMed
                                • Abstract available
                              8. Coomes SM, Wilke CA, Moore TA, Moore BB, et al.
                                • Induction of TGF-{beta}1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant.
                                • J Immunol. 2010.
                                • PubMed
                                • Abstract available
                              9. Wu B, Wang C, Dong G, Guo Y, et al.
                                • New Evidence Suggests Southern China as a Common Source of Multiple Clusters of Highly Pathogenic H5N1 Avian Influenza Virus.
                                • J Infect Dis. 2010.
                                • PubMed
                                • Abstract available
                              10. Dudek SE, Luig C, Pauli EK, Schubert U, et al.
                                • The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              11. Crepin T, Dias A, Palencia A, Swale C, et al.
                                • Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              12. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, et al.
                                • Adaptation of pandemic H1N1 influenza viruses in mice.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              13. Teijaro JR, Verhoeven D, Page CA, Turner D, et al.
                                • Memory CD4 T cells Direct Protective Responses to Influenza Virus in the Lung through Helper-independent Mechanisms.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              14. Kaminski A, Poyry TA, Skene PJ, Jackson RJ, et al.
                                • Mechanism of initiation site selection promoted by the human rhinovirus 2 internal ribosome entry site.
                                • J Virol. 2010;84:6578-89.
                                • PubMed
                                • Abstract available
                              15. Gilman SL.
                                • Moral panic and pandemics.
                                • Lancet. 2010;375:1866-7.
                                • PubMed
                              16. Hens N, Van Ranst M, Aerts M, Robesyn E, et al.
                                • Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: A multi-country analysis for influenza A/H1N1v 2009.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              17. Looijmans-van den Akker I, van Delden JJ, Verheij TJ, van der Sande MA, et al.
                                • Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              18. Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, et al.
                                • High costs of influenza: Direct medical costs of influenza disease in young children.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              19. Chen Y, Zhong G, Wang G, Deng G, et al.
                                • Dogs are highly susceptible to H5N1 avian influenza virus.
                                • Virology. 2010.
                                • PubMed
                                • Abstract available
                              20. Song JM, Hossain J, Yoo DG, Lipatov AS, et al.
                                • Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.
                                • Virology. 2010.
                                • PubMed
                                • Abstract available
                              21. Nguyen HT, Sheu TG, Mishin VP, Klimov AI, et al.
                                • Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
                                • Antimicrob Agents Chemother. 2010.
                                • PubMed
                                • Abstract available

                              -
                              ------

                              Comment


                              • #30
                                Research Articles Abstracts - July 9 2010 Issue

                                [Source: US National Library of Medicine, (LINK). Edited.]

                                Research Articles Abstracts - July 9 2010 Issue

                                1. Hurt AC, Lowther S, Middleton D, Barr IG, et al.
                                  • Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
                                  • Antiviral Res. 2010.
                                  • PubMed
                                  • Abstract available
                                2. Laurell AC, Herrera JR.
                                  • WHO and pandemic flu. What happened in Mexico.
                                  • BMJ. 2010;340:c3465.
                                  • PubMed
                                3. Kon P.
                                  • WHO and pandemic flu. GlaxoSmithKline UK responds.
                                  • BMJ. 2010;340:c3464.
                                  • PubMed
                                4. Chan M.
                                  • WHO Director-General replies to the BMJ.
                                  • BMJ. 2010;340:c3463.
                                  • PubMed
                                5. Jefferson T, Doshi P.
                                  • WHO and pandemic flu. Time for change, WHO.
                                  • BMJ. 2010;340:c3461.
                                  • PubMed
                                6. Law R.
                                  • WHO and pandemic flu. There was also no new subtype.
                                  • BMJ. 2010;340:c3460.
                                  • PubMed
                                7. Doshi P, Jefferson T.
                                  • WHO and pandemic flu. Another question for GSK.
                                  • BMJ. 2010;340:c3455.
                                  • PubMed
                                8. McLean E, Pebody RG, Campbell C, Chamberland M, et al.
                                  • Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases.
                                  • Epidemiol Infect. 2010.
                                  • PubMed
                                  • Abstract available
                                9. Maltezou HC, Dedoukou X, Patrinos S, Maragos A, et al.
                                  • Determinants of Intention to get vaccinated against Novel (Pandemic) Influenza A H1N1 among Health-Care Workers in a Nationwide Survey.
                                  • J Infect. 2010.
                                  • PubMed
                                  • Abstract available
                                10. Lalayianni C.
                                  • Outbreak of novel influenza a (h1n1) in an adult haematology department and haematopoietic cell transplantation unit: Clinical presentation and outcome.
                                  • J Infect. 2010.
                                  • PubMed
                                11. Chowell G, Viboud C, Simonsen L, Miller MA, et al.
                                  • Mortality Patterns Associated with the 1918 Influenza Pandemic in Mexico: Evidence for a Spring Herald Wave and Lack of Preexisting Immunity in Older Populations.
                                  • J Infect Dis. 2010.
                                  • PubMed
                                  • Abstract available
                                12. Acosta EP, Jester P, Gal P, Wimmer J, et al.
                                  • Oseltamivir Dosing for Influenza Infection in Premature Neonates.
                                  • J Infect Dis. 2010.
                                  • PubMed
                                  • Abstract available
                                13. Esposito DH, Gardner TJ, Schneider E, Stockman LJ, et al.
                                  • Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008.
                                  • J Infect Dis. 2010;202:214-22.
                                  • PubMed
                                  • Abstract available
                                14. Chidlow GR, Harnett GB, Williams SH, Tempone SS, et al.
                                  • The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.
                                  • J Virol Methods. 2010.
                                  • PubMed
                                  • Abstract available
                                15. Chapman GB, Li M, Colby H, Yoon H, et al.
                                  • Opting in vs opting out of influenza vaccination.
                                  • JAMA. 2010;304:43-4.
                                  • PubMed
                                16. Song H, Wittman V, Byers A, Tapia T, et al.
                                  • In vitro stimulation of human influenza-specific CD8(+) T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                17. Torun SD, Torun F.
                                  • Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                18. Lin J, Somanathan S, Roy S, Calcedo R, et al.
                                  • Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                19. Lu CY, Shao PL, Chang LY, Huang YC, et al.
                                  • Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                20. Oh CE, Lee J, Kang JH, Hong YJ, et al.
                                  • Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                21. Hara M, Tanaka K, Kase T, Maeda A, et al.
                                  • Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                22. Carmona A, Omenaca F, Tejedor JC, Merino JM, et al.
                                  • Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                23. Misplon JA, Lo CY, Gabbard JD, Tompkins SM, et al.
                                  • Genetic control of immune responses to influenza A matrix 2 protein (M2).
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                24. Keawcharoen J, Spronken MI, Vuong O, Bestebroer TM, et al.
                                  • Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                25. Kraigher A, Ucakar V.
                                  • Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                26. Bozzola E, Krzysztofiak A, Lancella L, Tozzi A, et al.
                                  • Risk factors of complicated H1N1 influenza in hospitalized Italian children.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                27. Riffault S, Meyer G, Deplanche M, Dubuquoy C, et al.
                                  • A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                28. Furuse Y, Shimabukuro K, Odagiri T, Sawayama R, et al.
                                  • Comparison of selection pressures on the HA gene of pandemic (2009) and seasonal human and swine influenza A H1 subtype viruses.
                                  • Virology. 2010.
                                  • PubMed
                                  • Abstract available

                                -
                                -----

                                Comment

                                Working...
                                X